MP Biomedicals, Leading Life Science and Diagnostics Product Provider, Launches New Automated Platform for Nucleic Acid Purification – MPure-12™
Santa Ana, California, February 9, 2015 -- MP Biomedicals, LLC, a leading provider of life science reagents, fine chemicals and diagnostic products for over 50 years, announced today it has launched the MPure-12™ System - an automated platform for the magnetic bead based purification of nucleic acids from a wide range of biological samples.
MPure-12™ system has an uniquely designed magnetic bead based processing chamber and is fully integrated with easy to use, sample specific, pre-packaged reagent kits to process a wide range of bio-specimens. This platform offers our customers superior yield, purity, reliable performance, flexibility and convenience, all at an affordable price. The system can process from one to twelve samples simultaneously and also incorporates features that eliminate any detectable cross contamination, nucleic acid loss and degradation, wastage of reagents, and simultaneously offer reproducibility, well-to-well consistency, scalability and ease-of-use.
"The MPure-12™ platform is one of the most advanced systems for the purification of nucleic acids (DNA & RNA) and offers superior yield and purity at an affordable price to our global customers. This system will be of value for anyone focused on genomics, NextGen Sequencing, epigenetics, gene expressions and forensic studies, all of which require DNA and RNA of the highest quality, purity and yield”, says Milan Panic, CEO and President. Mr. Panic was also the founder of the ICN Pharmaceuticals, from which MP Biomedicals was formed.
MPure-12™ platform incorporates new and innovative features that enable rapid and efficient purification of nucleic acids. These include the uniquely designed polygon reaction chamber, design of the liquid handling robotic platform, bar-code reader with pre-programmed protocol cards and a UV lamp. “We focus on innovation and have established ourselves as a global leader in sample preparation through the introduction of the FastPrep® system. MPure-12™ launch will enable us to continue our leadership position from sample preparation through purification”, says Milan Panic. To learn more about the MPure-12™ system, visit www.mpbio.com/mpure12.
About MP Biomedicals LLC
MP Biomedicals is a global corporation and world leader in life sciences, fine chemicals and diagnostics products. Our product portfolio of over 55,000 products represents one of the most exhaustive lists of time-tested brands including ICN, Qbiogene, Bio101, Flow Laboratories, Cappel, Genelabs, among others.
The MP Life Science Division supplies products and reagents for multiple life science applications, including sample preparation with its FastPrep® family of instruments and consumables, molecular biology, immunology, cell biology and biochemicals.
The company, with headquarters in Southern California, has ISO-certified and FDA-approved manufacturing and distribution facilities worldwide (Solon, OH; Burlingame, CA; Strasbourg, France; Germany; Singapore; Japan; Australia; New Zealand; Shanghai and Beijing, China; and Mumbai, India). A vast distributor network complements MP facilities throughout the world to assure customers delivery of top quality products when and where needed. For more information please visit www.mpbio.com.